- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05453656
Development and Testing of the Kidney BEAM-KIDS Digital Platform for Children After Kidney Transplantation (BEAM-KIDs)
Co-design, Development and Evaluation of the KIDNEY BEAM-KIDS Platform for Paediatric Kidney Transplant Recipients: a Feasibility Study
Study Overview
Detailed Description
Kidney transplantation (KT) is the preferred and most prevalent treatment in CYP with CKD but is associated with increased risk of cardiovascular complications, insulin resistance, and diabetes, with likely contributors being visceral obesity and low lean body mass. In general paediatric populations, all of the above are favourably modified by regular/varied PA. The benefits and risks of PA for CYP with CKD are, however, less well established and available data are mainly from cross-sectional studies. Kidney-BEAM is a digital health platform for adults with CKD, which provides live and on-demand exercise classes. The investigators propose to adapt the kidney BEAM platform to kidney BEAM-KIDS for CYP with CKD to access activities adapted to their needs and document benefits on outcomes that matter to them.
Aims and methods: A single-arm, multi-centre, feasibility study, with a mixed-method design using an effectiveness and theory-based perspective. Investigators will examine the feasibility and acceptability of (a) Kidney BEAM-KIDS as the intervention and delivery setting in CYP following KT, and (b) the evaluation design for addressing all recommended core elements (context, engaging stakeholders, identifying key uncertainties, refining the intervention, economic considerations) to inform the development of a clinical evaluation trial The team will aim to recruit about 30 participants between 6-17 years of age. Research questions:
- What are participants' experiences of Kidney BEAM-KIDS and views on its feasibility, acceptability and benefits?
- What type and quantity of adverse events (if any) are experienced over an observation period of 7-12 months?
- What are the study recruitment and retention rates?
- What is the acceptability of data collection methods and rate of outcome measure completion?
- What are the variability and patterns of change in outcomes to determine a primary outcome measure and calculate sample size for a future study?
- What is the feasibility of a future health economic evaluation?
Outcomes: Quantitive data: demographic, clinical and physical characteristics, adverse events and hospitalisations, 4-7 day dietary intake diaries, at 3 time points: before and after KT and after 12 weeks exposure to Kidney BEAM-KIDS. Selection of outcomes was based on i) the potential impact on outcomes that matter to CYP (multidimensional PedsQLv4, self perception profile, Physical activity questionnaire, BEAM-KIDS platform use metrics), (ii) participants' wide age range (6-17 years), and iii) the need to minimise face-to-face assessments where possible due to the wide geographical spread of recruiting centres. Physical function outcomes (strength and cardiorespitatory fitness) will be collected in person if possible. Qualitative data: via remote semi-structured individual interviews and focus groups using a process evaluation approach to explore experiences, attitudes, preferences, suggestions to inform future directions.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Pelagia Koufaki, PhD
- Phone Number: 01314740000
- Email: pkoufaki@qmu.ac.uk
Study Contact Backup
- Name: Sharlene Greenwood, PhD
- Phone Number: 0131 474 0000
- Email: sharlene.greenwood@nhs.net
Study Locations
-
-
-
Glasgow, United Kingdom
- Recruiting
- Glasgow Royal Hospital for Children
-
Contact:
- Reynolds
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- CYP of school age between 6 and 17 years attending a paediatric transplant centre
- Likely to require a KT within 12 months
- No intended date of transition to adult services within 12 months
Exclusion Criteria:
- Inability or absolute contraindications to engaging in PA
- Severe bone disease
- Cancer/leukaemia or HIV treatment within the 12 months before enrolment
- Enrolment in other clinical trials in which treatment is masked.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: exercise
live and on demand exercise sessions on the Kidney BEAM-KIDS platform
|
physical activity promotion and engagement following kidney transplantation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life score
Time Frame: change from baseline to 12 and 24 weeks post kidney transplantation and exercise
|
the multidimensional PedsQLv4 questionnaire and relevant sub-module questionnaires on fatigue and transplantation will be used to estimate scores that reflect the domains of physical functioning, emotional functioning, social functioning, school functioning, general fatigue, sleep/rest fatigue and cognitive fatigue, treatment anxiety
|
change from baseline to 12 and 24 weeks post kidney transplantation and exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency and type of physical activity
Time Frame: change from baseline to 12 and 24 weeks post kidney transplantation and exercise
|
the self-reported Physical Activity Questionnaire - PAQ for CYP will be used to capture data on PA patterns
|
change from baseline to 12 and 24 weeks post kidney transplantation and exercise
|
|
type and quantity of food groups consumed
Time Frame: change from baseline to 12 and 24 weeks post kidney transplantation and exercise
|
4-7 day diaries will be used to capture and analyse nutritional intake information
|
change from baseline to 12 and 24 weeks post kidney transplantation and exercise
|
|
adverse events
Time Frame: change from baseline to 12 and 24 weeks post kidney transplantation and exercise
|
episodes of hospitalisations and other infection events will be captured via medical records
|
change from baseline to 12 and 24 weeks post kidney transplantation and exercise
|
|
kidney BEAM-KIDS platform metrics
Time Frame: change from 12 weeks post kidney transplantation to 12 weeks post exercise
|
minutes spent on physical activity and engagement with the digital health platform
|
change from 12 weeks post kidney transplantation to 12 weeks post exercise
|
|
qualitative exploration of trial acceptability and participant experience
Time Frame: at 12 weeks post kidney transplantation
|
focus groups and semi structured interviews with participants and families will be used to capture qualitative data
|
at 12 weeks post kidney transplantation
|
|
qualitative exploration of trial acceptability and participant experience
Time Frame: at 12 weeks post exercise
|
focus groups and semi structured interviews with participants and families will be used to capture qualitative data
|
at 12 weeks post exercise
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P2008QMU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Transplantation
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedKidney Transplantation | Renal Transplantation | Transplantation, Kidney | Grafting, Kidney | Transplantation, RenalBelgium, Germany, Spain, Sweden, Italy, Switzerland, United Kingdom, Austria, France, Poland, Czech Republic, Netherlands
-
Bristol-Myers SquibbCompletedKidney Transplantation: Transplantation, Kidney
-
Hospices Civils de LyonCompletedKidney Transplantation | Pancreas-kidney TransplantationFrance
-
Nantes University HospitalTerminated
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationSpain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCzechia, France, Italy, Poland, United Kingdom
-
Astellas Pharma Europe Ltd.TerminatedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
The Hospital for Sick ChildrenCompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCanada
-
Medical University of ViennaUnknownKidney Function After Transplantation | Outcome After Kidney Transplantation
Clinical Trials on exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University of Missouri-ColumbiaCompleted
-
University of AlcalaCompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point PainSpain
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Bayero University Kano, NigeriaCompletedChronic Low Back PainNigeria
-
University College CorkRecruitingDepressive Disorder, MajorIreland